We examined in fully mismatched rats, the survival of pancreatic islet
allografts in recipients treated with either fusidic acid (FA), an an
tistaphyllococcal antibiotic that has been shown to possess an immunos
uppressive effect in vitro and in vivo, or cyclosporin-A (CsA), Islets
were isolated by collagenase digestion, separated from acinar tissue
by handpicking under a dissecting microscope and transplanted into the
liver by portal vein injection of streptozotocin (STZ)-induced diabet
ic rats, The results indicated that while a temporary immunosuppressio
n with CsA achieved an indefinite islet allograft survival, FA adminis
tered to recipients daily was not able to prevent islet allograft reje
ction across a major histocompatibility barrier, We conclude that desp
ite the fact that fusidic acid has been claimed to act as an immunosup
pressant drug in vitro with effects similar to those of CsA, unlike Cs
A, FA given either orally or by s.c. injection was not effective to pr
olong islet allograft survival in vivo. Copyright (C) 1997 Elsevier Sc
ience Inc.